Roth capital research reports

2020-01-22 19:18

Roth Capital set a 27. 00 price objective on Acushnet (NYSE: GOLF) in a research report released on Thursday morning, TipRanks reports. The brokerage currently has a hold rating on the stock. Other equities analysts have also recently issued research reports about the stock.ROTH Capital Partners is a full service investment banking firm dedicated to the smallcap public market. ROTH offers its clients a full spectrum of investment banking services, including capital raising, research coverage, trading and market making, merger roth capital research reports

May 10, 2019  Disclosures from ROTH Capital Partners, Endeavour Silver Corp. , Company Note, May 6, 2019 Regulation Analyst Certification ( Reg AC ): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report

Roth capital research reports free

May 31, 2017  ROTH Capital Partners Expands Consumer Research Coverage with Addition of David B. Bain as a Senior Research Analyst in Gaming, Leisure

May 12, 2019 Roth Capital restated their neutral rating on shares of Farmer Bros (NASDAQ: FARM) in a research report report published on Wednesday, Briefing. com Automated Import reports. Roth Capital currently has a 20. 00 price target on the stock, down from their previous price target of 28. 00.

Roth Capitals price objective would indicate a potential [ Fluent (NASDAQ: FLNT) was upgraded by analysts at Roth Capital from a neutral rating to a buy rating in a research report issued on Thursday, Briefing. com Automated Import reports.

May 08, 2019  In an April 29 research report, analyst Jotin Marango reported that ROTH Capital Partners raised its price target on ArQule Inc. (ARQL: NASDAQ) to 10 per share in anticipation of a clinical update on its ARQ531 dose escalation study in chronic

Nov 07, 2014  In a research report sent to investors today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Spectrum Pharmaceuticals (NASDAQ: SPPI) with

May 07, 2019 Roth Capital Partners, LLC company research& investing information. Find executives and the latest company news.

Roth Capital currently has 3. 00 price objective on the stock. A number of other research analysts also recently issued reports on HZN. Zacks Investment Research upgraded shares of Horizon Global from a strong sell rating to a hold rating in a research note on Thursday, January 10th.

Rating: 4.64 / Views: 784

Lydall (NYSE: LDL) has been given a 24. 00 price target by Roth Capital in a research report issued to clients and investors on Thursday, TipRanks reports. The brokerage presently has a hold rating on the auto parts companys stock. Roth Capitals price target would suggest a potential upside of 7. 29 from the companys current price.

2020 (c) boprecon | Sitemap